Dr. Drew W Rasco, MD
Claim this profileSouth Texas Accelerated Research Therapeutics (START)
Expert in Tumors
Studies Solid Tumors
19 reported clinical trials
32 drugs studied
About Drew W Rasco, MD
Education:
- Earned an MD from the University of Texas Health Sciences Center, San Antonio, TX, in 2003.
Experience:
- Completed residency in Internal Medicine at Emory University School of Medicine, Atlanta, GA.
- Fellowships in Hematology and Oncology at the University of Texas Southwestern Medical Center, Dallas, TX.
- Board-certified in Hematology and Oncology.
- Associate Director of Clinical Research at South Texas Accelerated Research Therapeutics (START).
- Principal investigator for research leading to FDA approval of treatments, including the combination of lenvatinib and pembrolizumab for endometrial cancer in 2019.
Area of expertise
1Tumors
Global LeaderStage IV
Stage III
ARID1A positive
2Solid Tumors
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials Drew W Rasco, MD is currently running
CLN-619 + Pembrolizumab
for Cancer
This trial is testing a new drug called CLN-619 alone and with pembrolizumab in patients with advanced solid tumors. These patients may not have other treatment options. Pembrolizumab helps the immune system fight cancer, and they are seeing if CLN-619 can help too.
Recruiting1 award Phase 110 criteria
MT-6402
for Solid Cancers
This will be a Phase 1 Open-label, dose escalation and expansion study of MT-6402 (an Engineered Toxin Body (ETB)) in subjects with advanced solid cancer that expresses PD-L1
Recruiting1 award Phase 110 criteria
More about Drew W Rasco, MD
Clinical Trial Related8 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 11 Active Clinical TrialsTreatments Drew W Rasco, MD has experience with
- Pembrolizumab
- Dostarlimab
- CPI-0209
- APG-1387
- Ketogenic Diet
- Zimberelimab
Breakdown of trials Drew W Rasco, MD has run
Tumors
Solid Tumors
Prostate Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Drew W Rasco, MD specialize in?
Drew W Rasco, MD focuses on Tumors and Solid Tumors. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage III.
Is Drew W Rasco, MD currently recruiting for clinical trials?
Yes, Drew W Rasco, MD is currently recruiting for 11 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Drew W Rasco, MD has studied deeply?
Yes, Drew W Rasco, MD has studied treatments such as Pembrolizumab, Dostarlimab, CPI-0209.
What is the best way to schedule an appointment with Drew W Rasco, MD?
Apply for one of the trials that Drew W Rasco, MD is conducting.
What is the office address of Drew W Rasco, MD?
The office of Drew W Rasco, MD is located at: South Texas Accelerated Research Therapeutics (START), San Antonio, Texas 78229 United States. This is the address for their practice at the South Texas Accelerated Research Therapeutics (START).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.